Works matching AU Zhen, Huiling

Results: 7

A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.

Published in:

2018

By:

Giaccone, Giuseppe;
Sanborn, Rachel E.;
Waqar, Saiama N.;
Martinez-Marti, Alex;
Ponce, Santiago;
Huiling Zhen;
Kennealey, Gerard;
Erickson-Viitanen, Susan;
Schaefer, Eric;
Zhen, Huiling

Publication type:

journal article

Enhanced machine learning models for predicting three-year mortality in Non-STEMI patients aged 75 and above.

Published in:

BMC Geriatrics, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12877-025-06128-9

By:

Zhang, Jing;
Xiong, Wuyu;
Zhang, Chengzhi;
Huang, Cuiyuan;
Li, Wenqiang;
Liu, Li;
Wang, Wei;
Sang, Ye;
Zhen, Huiling;
Tan, Caiwei;
Yang, Jiajuan;
Yang, Jian

Publication type:

Article

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 14, doi. 10.1634/theoncologist.2017-0665

By:

Beatty, Gregory L.;
Shahda, Safi;
Beck, Thaddeus;
Uppal, Nikhil;
Cohen, Steven J.;
Donehower, Ross;
Gabayan, Afshin Eli;
Assad, Albert;
Switzky, Julie;
Zhen, Huiling;
Von Hoff, Daniel D.

Publication type:

Article

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.

Published in:

2018

By:

Kiladjian, Jean-Jacques;
Guglielmelli, Paola;
Griesshammer, Martin;
Saydam, Guray;
Masszi, Tamas;
Durrant, Simon;
Passamonti, Francesco;
Jones, Mark;
Zhen, Huiling;
Li, Jingjin;
Gadbaw, Brian;
Perez Ronco, Julian;
Khan, Mahmudul;
Verstovsek, Srdan

Publication type:

journal article

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).

Published in:

British Journal of Haematology, 2017, v. 176, n. 1, p. 76, doi. 10.1111/bjh.14382

By:

Mesa, Ruben;
Vannucchi, Alessandro M.;
Yacoub, Abdulraheem;
Zachee, Pierre;
Garg, Mamta;
Lyons, Roger;
Koschmieder, Steffen;
Rinaldi, Ciro;
Byrne, Jennifer;
Hasan, Yasmin;
Passamonti, Francesco;
Verstovsek, Srdan;
Hunter, Deborah;
Jones, Mark M.;
Zhen, Huiling;
Habr, Dany;
Martino, Bruno

Publication type:

Article

Phase 2, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Patients with Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S350, doi. 10.1016/j.clml.2017.07.176

By:

Verstovsek, Srdan;
Rambaldi, Alessandro;
Lihou, Christine;
Zhen, Huiling;
Hochhaus, Andreas

Publication type:

Article

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.

Published in:

European Journal of Haematology, 2016, v. 97, n. 2, p. 192, doi. 10.1111/ejh.12707

By:

Mesa, Ruben;
Verstovsek, Srdan;
Kiladjian, Jean‐Jacques;
Griesshammer, Martin;
Masszi, Tamas;
Durrant, Simon;
Passamonti, Francesco;
Harrison, Claire N.;
Pane, Fabrizio;
Zachee, Pierre;
Zhen, Huiling;
Jones, Mark M.;
Parasuraman, Shreekant;
Li, Jingjin;
Côté, Isabelle;
Habr, Dany;
Vannucchi, Alessandro M.

Publication type:

Article